Prevention of homozygous beta-thalassemia by carrier screening and prenatal diagnosis in Sardinia
- PMID: 7258188
- PMCID: PMC1685095
Prevention of homozygous beta-thalassemia by carrier screening and prenatal diagnosis in Sardinia
Abstract
We report here results of a 3-year pilot voluntary screening program coupled with prenatal diagnosis directed to the prospective prevention of homozygous beta-thalassemia (beta-thal) in Sardinia. The screening program took two approaches: outreach community testing and hospital testing on request after a period of sensibilization. The outreach testing was very effective as, taking into account the already known number of couples at risk with an affected proband (20), 74% of the couple at risk expected (61) on the basis of the carrier rate were identified. Less effective was the hospital testing in which half of the couples at risk expected were detected (502 with the 199 without an affected proband). After nondirective genetic counseling, approximately 85% of the couples at risk, which had a pregnancy, with no statistically significant difference between those with and those without a proband, requested prenatal testing. This figure showed a steadily increase from the beginning in 1977 to 1980. All the pregnancies (42), but two carrying homozygous fetuses, were terminated on parental request. A continuous hospital survey of thal-major admissions in the different hospitals of the counties showed a steady decline in the incidence figure at birth from 1976 (1:213) to 1978 (1:290). These results showed that even in a medium-developed, rural, Catholic population screening coupled with prenatal diagnosis can be successful in the control of a fatal, recessively inherited disorder.
Similar articles
-
Control of homozygous beta-thalassemia by carrier screening and antenatal diagnosis in Sardinians.Clin Genet. 1984 Jul;26(1):12-22. doi: 10.1111/j.1399-0004.1984.tb00781.x. Clin Genet. 1984. PMID: 6205797
-
Thalassemia heterozygotes in Hawaii: ethnic attitudes toward screening and prenatal diagnosis.Hemoglobin. 1988;12(5-6):801-16. doi: 10.3109/03630268808991673. Hemoglobin. 1988. PMID: 3209417
-
Carrier screening for alpha- and beta-thalassemia in pregnancy: the results of an 11-year prospective program in Guangzhou Maternal and Neonatal hospital.Prenat Diagn. 2005 Feb;25(2):163-71. doi: 10.1002/pd.1079. Prenat Diagn. 2005. PMID: 15712323
-
Antenatal diagnosis of beta-thalassemia in Sardinia.Ann N Y Acad Sci. 1990;612:215-25. doi: 10.1111/j.1749-6632.1990.tb24309.x. Ann N Y Acad Sci. 1990. PMID: 2291548 Review.
-
Carrier screening and genetic counselling in beta-thalassemia.Int J Hematol. 2002 Aug;76 Suppl 2:105-13. doi: 10.1007/BF03165098. Int J Hematol. 2002. PMID: 12430909 Review.
Cited by
-
Considerations on the use of carrier screening testing in human reproduction: comparison between recommendations from the Italian Society of Human Genetics and other international societies.J Assist Reprod Genet. 2022 Nov;39(11):2581-2593. doi: 10.1007/s10815-022-02653-3. Epub 2022 Nov 12. J Assist Reprod Genet. 2022. PMID: 36370240 Free PMC article. Review.
-
Blood Demand and Challenges for Patients With Beta-Thalassemia Major in Eastern Saudi Arabia.Cureus. 2021 Aug 26;13(8):e17470. doi: 10.7759/cureus.17470. eCollection 2021 Aug. Cureus. 2021. PMID: 34603865 Free PMC article.
-
Expanded universal carrier screening and its implementation within a publicly funded healthcare service.J Community Genet. 2020 Jan;11(1):21-38. doi: 10.1007/s12687-019-00443-6. Epub 2019 Dec 11. J Community Genet. 2020. PMID: 31828606 Free PMC article. Review.
-
Innovation for rare diseases and bioethical concerns: A thin thread between medical progress and suffering.World J Clin Pediatr. 2018 Aug 30;7(3):75-82. doi: 10.5409/wjcp.v7.i3.75. eCollection 2018 Aug 30. World J Clin Pediatr. 2018. PMID: 30191136 Free PMC article.
-
Comment to the article "prevention of B thalassemia in northern Israel - a cost-benefit analysis" by koren et Al.Mediterr J Hematol Infect Dis. 2014 Mar 9;6(1):e2014021. doi: 10.4084/MJHID.2014.021. eCollection 2014. Mediterr J Hematol Infect Dis. 2014. PMID: 24678398 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical